Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0476089 (
endometrial cancer
)
11,379
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Endometrioid
endometrial carcinoma
(
EEC
) is one of the common causes of cancer-related mortality in women. Mounting evidences suggest that long noncoding RNAs (lncRNAs) function in multiple cancers. In this study, we discovered that HAND2-AS1, a lncRNA transcribed antisense adjacent to Heart and Neural Crest Derivatives Expressed 2 (HAND2) in chromosome 4q33-34, is significantly down-regulated in
EEC
. HAND2-AS1 and HAND2 were frequently down-regulated in
EEC
tissues, especially in poor differentiated tumor tissues. Down-regulation of HAND2-AS1 and HAND2 was correlated with tumor grade, lymph node metastasis and recurrence of
EEC
patients. HAND2-AS1 and HAND2 were co-downregulated by promoter DNA hypermethylation in
EEC
. Overexpression of HAND2-AS1 in
EEC
cells demonstrated that HAND2-AS1 suppressed migration and invasion of
EEC
cells. Similarly, overexpression of HAND2 also inhibited migration and invasion
EEC
cells indicating that HAND2-AS1 and HAND2 had a concordant role in the progression of
EEC
. However, HAND2 was not regulated by HAND2-AS1 in
EEC
. Furthermore, the anti-tumorigenic effect of HAND2-AS1 was mediated by down-regulating
NMU
, which has an oncogenic role in
EEC
. Our findings therefore provide the first evidence that HAND2-AS1 is a critical tumor suppressor in
EEC
.
...
PMID:Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U. 2910 8